Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening

Journal of Sexual Medicine

Volumn 5, Issue 9, 2008, Pages 2141-2151

  Bhojani, Naeem ^a,b   Perrotte, Paul ^a   Hutterer, Georg ^c   Suardi, Nazareno ^a,d   Jeldres, Claudio ^a,b   Shariat, Shahrokh F ^e   Capitanio, Umberto ^a   Arjane, Philippe ^b   Widmer, Hugues ^b   Benard, Francois ^b   Peloquin, Francois ^b   Montorsi, Francesco ^d   Karakiewicz, Pierre ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Body Mass Index; Chronic Prostatitis; Ejaculatory Pain; Erectile Dysfunction; Lower Urinary Tract Symptoms

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER SCREENING; CHRONIC PROSTATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HIGH RISK POPULATION; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; SPERMATOZOON DENSITY; UROGENITAL TRACT DISEASE;

EID: 51349113495     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00811.x     Document Type: Article

References (53)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the united States, 1999-2004. JAMA 2006;295:1549-55.
2. Fontaine KR, Heo M, Allison DB. Obesity and prostate cancer screening in the USA. Public Health 2005;119:694-8.
3. Seidell JC. Obesity in Europe: Scaling an epidemic. Int J Obes Relat Metab Disord 1995;19(3suppl):S1-4.
4. Pietinen P, Vartiainen E, Mannisto S. Trends in body mass index and obesity among adults in Finland from 1972 to 1992. Int J Obes Relat Metab Disord 1996;20:114-20.
5. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
6. Muller A, Mulhall JP. Cardiovascular disease, metabolic syndrome and erectile dysfunction. Curr Opin Urol 2006;16:435-43.
7. Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Thomas S, Bosch JL. Correlates for erectile and ejaculatory dysfunction in older Dutch men: A community-based study. J Am Geriatr Soc 2001;49:436-42.
8. Aytac IA, Araujo AB, Johannes CB, Kleinman KP, McKinlay JB. Socioeconomic factors and incidence of erectile dysfunction: Findings of the longitudinal Massachussetts Male Aging Study. Soc Sci Med 2000;51:771-8.
9. Walczak MK, Lokhandwala N, Hodge MB, Guay AT. Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002;5:19-24.
10. Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ, Park K, Park H, Hyun JS. Prevalence and risk factors for erectile dysfunction in Korean men: Results of an epidemiological study. J Sex Med 2007;4:1269-76.
11. Mulhall J, Teloken P, Brock G, Kim E. Obesity, dyslipidemias and erectile dysfunction: A report of a subcommittee of the sexual medicine society of North America. J Sex Med 2006;3:778-86.
12. El-Sakka AI, Hassoba HM, Sayed HM, Tayeb KA. Pattern of endocrinal changes in patients with sexual dysfunction. J Sex Med 2005;2:551-8.
13. Zohdy W, Kamal EE, Ibrahim Y. Androgen deficiency and abnormal penile duplex parameters in obese men with erectile dysfunction. J Sex Med 2007;4:797-808.
14. Wingard C, Fulton D, Husain S. Altered penile vascular reactivity and erection in the Zucker obese-diabetic rat. J Sex Med 2007;4:348-62 (discussion 62-3).
15. Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998;1:157-62.
16. Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H, Gokkaya S, Memis A. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 2007;51:199-203 (discussion 4-6).
17. Kasturi S, Russell S, McVary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep 2006;7:288-92.
18. Paick JS, Yang JH, Kim SW, Ku JH. Are age, anthropometry and components of metabolic syndrome-risk factors interrelated with lower urinary tract symptoms in patients with erectile dysfunction? A prospective study. Asian J Androl 2007;9:213-20.
19. McVary K. Lower urinary tract symptoms and sexual dysfunction: Epidemiology and pathophysiology. BJU Int 2006;97(2 suppl):23-8 (discussion 44-5).
20. Guay A, Jacobson J. The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction. J Sex Med 2007;4:1046-55.
21. Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD, Lotti F, Chiarini V, Fedele D, Forti G, Maggi M. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 2007;4:1038-45.
22. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346-51.
23. Barry MJ, Fowler FJ Jr., O'Leary, MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57 (discussion 64).
24. Karakiewicz PI, Perrotte P, Valiquette L, Benard F, McCormack M, Menard C, McNaughton Collins M, Nickel JC. French-Canadian linguistic validation of the NIH Chronic Prostatitis Symptom Index. Can J Urol 2005;12:2816-23.
25. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991;138:59-62.
26. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8.
27. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-42.
28. Gunduz MI, Gumus BH, Sekuri C. Relationship between metabolic syndrome and erectile dysfunction. Asian J Androl 2004;6:355-8.
29. Kupelian V, Shabsigh R, Araujo AB, O'Donnell AB, McKinlay JB. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: Results from the Massachusetts Male Aging Study. J Urol 2006;176:222-6.
30. Moreira ED Jr, Lisboa Lobo CF, Villa M, Nicolosi A, Glasser DB. Prevalence and correlates of erectile dysfunction in Salvador, northeastern Brazil: A population-based study. Int J Impot Res 2002;14(2 suppl):S3-9.
31. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM, Giugliano D. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-9.
32. Rohrmann S, Smit E, Giovannucci E, Platz EA. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2004;159:390-7.
33. El-Sakka AI. Lower urinary tract symptoms in patients with erectile dysfunction: Analysis of risk factors. J Sex Med 2006;3:144-9.
34. Braun MH, Sommer F, Haupt G, Mathers MJ, Reifenrath B, Engelmann UH. Lower urinary tract symptoms and erectile dysfunction: Co-morbidity or typical "Aging Male"symptoms? Results of the "Cologne Male Survey". Eur Urol 2003;44:588-94.
35. Frankel SJ, Donovan JL, Peters TI, Abrams P, Dabhoiwala NF, Osawa D, Lin AT. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998;51:677-85.
36. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: Results of the Epidemiologia de la Disfuncion Erectil Masculina Study. J Urol 2001;166:569-74 (discussion 74-5).
37. Russell S, McVary KT. Lower urinary tract symptoms and erectile dysfunction: Epidemiology and treatment in the aging man. Curr Urol Rep 2005;6:445-53.
38. McVary KT. BPH: Epidemiology and comorbidities. Am J Manag Care 2006;12:S122-8.
39. Nickel JC, Elhilali M, Vallancien G. Benign prostatic hyperplasia (BPH) and prostatitis: Prevalence of painful ejaculation in men with clinical BPH. BJU Int 2005;95:571-4.
40. Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, O'Leary MP, Puppo P, Robertson C, Giuliano F. Lower urinary tract symptoms and male sexual dysfunction: The multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637-49.
41. Walz J, Perrotte P, Gallina A, Benard F, Valiquette L, McCormack M, Montorsi F, Karakiewicz PI. Ejaculatory disorders may affect screening for prostate cancer. J Urol 2007;178:232-7 (discussion 7-8).
42. Litwin MS, McNaughton-Collins M, Fowler FJ Jr., Nickel, JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O'Leary, MP. The National Institutes of Health chronic prostatitis symptom index: Development and validation of a new outcome measure Chronic Prostatitis Collaborative Research Network. J Urol 1999;162:369-75.
43. van Haarst EP, Heldeweg EA, Newling DW, Schlatmann TJ. A cross-sectional study of the international prostate symptom scores related to age and gender in Dutch adults reporting no voiding complaints. Eur Urol 2005;47:334-9.
44. Roumeguere T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 2003;44:355-9.
45. Bal K, Oder M, Sahin AS, Karatas CT, Demir O, Can E, Gumus BH, Ozer K, Sahin O, Esen AA. Prevalence of metabolic syndrome and its association with erectile dysfunction among urologic patients: Metabolic backgrounds of erectile dysfunction. Urology 2007;69:356-60.
46. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction, coronary artery disease: Common links. Eur Urol 2007 Dec;52(6):1590-600.
47. Haro JM, Beardsworth A, Casariego J, Gavart S, Hatzichristou D, Martin-Morales A, Schmitt H, Mirone V, Needs N, Riley A, Varanese L, von Keitz A, Kontodimas S. Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the Erectile Dysfunction Observational Study. J Sex Med 2006;3:530-40.
48. Kratzik CW, Schatzl G, Lunglmayr G, Rucklinger E, Huber J. The impact of age, body mass index and testosterone on erectile dysfunction. J Urol 2005;174:240-3.
49. Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I. The prevalence of erectile dysfunction in the primary care setting: Importance of risk factors for diabetes and vascular disease. Arch Intern Med 2006;166:213-9.
50. Haidinger G, Madersbacher S, Waldhoer T, Lunglmayr G, Vutuc C. The prevalence of lower urinary tract symptoms in Austrian males and associations with sociodemographic variables. Eur J Epidemiol 1999;15:717-22.
51. Lekili M, Muezzinoglu T, Uyanik BS, Buyuksu C. Serum lipid levels in benign prostatic hyperplasia. World J Urol 2006;24:210-3.
52. Morrison JA, Friedman LA, Gray-McGuire C. Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: The Princeton Lipid Research Clinics Follow-up Study. Pediatrics 2007;120:340-5.
53. Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, Willett WC. Obesity and benign prostatic hyperplasia. Am J Epidemiol 1994;140:989-1002.